References
- Clynes MA, Harvey NC, Curtis EM, Fuggle NR, Dennison EM, Cooper C. The epidemiology of osteoporosis. Br Med Bull. 2020;133(1):105–117. doi:https://doi.org/10.1093/bmb/ldaa005.
- Cummings SR, Melton III LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002;359:1761–1767. doi:https://doi.org/10.1016/S0140-6736(02)08657-9.
- Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science (80-). 1999;284(5411):143–147. doi:https://doi.org/10.1126/science.284.5411.143.
- Chan CKF, Gulati GS, Sinha R, et al. Identification of the human skeletal stem. Cell. Cell. 2018;175(1):43–56.e21. doi:https://doi.org/10.1016/j.cell.2018.07.029.
- Rauch A, Haakonsson AK, Madsen JGSS, et al. Network of stem cell transcription factors that act as repressors of adipogenesis. Nat Genet. 2019;51(4):716–727. doi:https://doi.org/10.1038/s41588-019-0359-1.
- Takeuchi R, Katagiri W, Endo S, Kobayashi T. Exosomes from conditioned media of bone marrow-derived mesenchymal stem cells promote bone regeneration by enhancing angiogenesis. PLoS One. 2019;14(11):e0225472. doi:https://doi.org/10.1371/journal.pone.0225472.
- Yang X, Yang J, Lei P, Wen T. LncRNA MALAT1 shuttled by bone marrow-derived mesenchymal stem cells-secreted exosomes alleviates osteoporosis through mediating microRNA-34c/SATB2 axis. Aging (Albany NY). 2019;11(20):8777–8791. doi:https://doi.org/10.18632/aging.102264.
- Crivelli B, Chlapanidas T, Perteghella S, et al. Mesenchymal stem/stromal cell extracellular vesicles: from active principle to next generation drug delivery system. J Control Release. 2017;262:104–117.
- Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringdén O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol. 2003;31(10):890–896. doi:https://doi.org/10.1016/S0301-472X(03)00110-3.
- Farr JN, Khosla S. Cellular senescence in bone. Bone. 2019;121(January):121–133. doi:https://doi.org/10.1016/j.bone.2019.01.015.
- Farr JN, Fraser DG, Wang H, Jaehn K, Ogrodnik MB, Weivoda MM, Drake MT, Tchkonia T, LeBrasseur NK, Kirkland JL, Bonewald LF, Pignolo RJ, Monroe DG, Khosla S. Identification of senescent cells in the bone microenvironment. J Bone Miner Res. 2016;31(11):1920–1929. doi:https://doi.org/10.1002/jbmr.2892.
- Farr JN, Xu M, Weivoda MM, Monroe DG, Fraser DG, Onken JL, Negley BA, Sfeir JG, Ogrodnik MB, Hachfeld CM, LeBrasseur NK, Drake MT, Pignolo RJ, Pirtskhalava T, Tchkonia T, Oursler MJ, Kirkland JL, Khosla S. Targeting cellular senescence prevents age-related bone loss in mice. Nat Med. 2017;23(9):1072–1079. doi:https://doi.org/10.1038/nm.4385.
- Del Real A, Pérez-Campo FM, Fernández AF, Sañudo C, Ibarbia CG, Pérez-Núñez MI, Criekinge WV, Braspenning M, Alonso MA, Fraga MF, Riancho JA. Differential analysis of genome-wide methylation and gene expression in mesenchymal stem cells of patients with fractures and osteoarthritis. Epigenetics. 2017;12(2):113–122. doi:https://doi.org/10.1080/15592294.2016.1271854.
- Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139–140. doi:https://doi.org/10.1093/bioinformatics/btp616.
- Alimbetov D, Davis T, Brook AJC, Cox LS, Faragher RGA, Nurgozhin T, Zhumadilov Z, Kipling D. Suppression of the senescence-associated secretory phenotype (SASP) in human fibroblasts using small molecule inhibitors of p38 MAP kinase and MK2. Biogerontology. 2016;17(2):305–315. doi:https://doi.org/10.1007/s10522-015-9610-z.
- Coppé J-P, Desprez P-Y, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol Mech Dis. 2010;5(1):99–118. doi:https://doi.org/10.1146/annurev-pathol-121808-102144.
- Salama R, Sadaie M, Hoare M, Narita M. Cellular senescence and its effector programs. Genes Dev. 2014;28(2):99–114. doi:https://doi.org/10.1101/gad.235184.113.
- Kjærgaard K, Dreyer CH, Ditzel N, Andreasen CM, Chen L, Sheikh SP, Overgaard S, Ding M. Bone formation by sheep stem cells in an ectopic mouse model: comparison of adipose and bone marrow derived cells and identification of donor-derived bone by antibody staining. Stem Cells Int. 2016;2016:3846971. doi:https://doi.org/10.1155/2016/3846971.
- Abdallah BM, Ditzel N, Kassem M. Assessment of bone formation capacity using in vivo transplantation assays: procedure and tissue analysis. Methods Mol Biol. 2008;455:89–100.
- Pérez-Campo FM, May T, Zauers J, et al. Generation and characterization of two immortalized human osteoblastic cell lines useful for epigenetic studies. J Bone Miner Metab. 2016;35(2):1–11. doi:https://doi.org/10.1007/s00774-016-0805-4.
- Mankani MH, Kuznetsov SA, Fowler B, Kingman A, Robey PG. In vivo bone formation by human bone marrow stromal cells: effect of carrier particle size and shape. Biotechnol Bioeng. 2001;72(1):96–107. doi:https://doi.org/10.1002/1097-0290(20010105)72:1<96::AID-BIT13>3.0.CO;2-A.
- Mankani MH, Kuznetsov SA, Marshall GW, Robey PG. Creation of new bone by the percutaneous injection of human bone marrow stromal cell and HA/TCP suspensions. Tissue Eng – Part A. 2008;14(12):1949–1958. doi:https://doi.org/10.1089/ten.tea.2007.0348.
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods. 2001;25(4):402–408. doi:https://doi.org/10.1006/meth.2001.1262.
- Stein GS, Lian JB. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev. 1993;14(4):424–442. doi:https://doi.org/10.1210/edrv-14-4-424.
- López-Delgado L, Riancho-Zarrabeitia L, Riancho JAJA, Lopez-Delgado L, Riancho-Zarrabeitia L, Riancho JAJA. Genetic and acquired factors influencing the effectiveness and toxicity of drug therapy in osteoporosis. Expert Metab Toxicol. 2016;12(4):389–398. doi:https://doi.org/10.1517/17425255.2016.1154533.
- Ichioka N, Inaba M, Kushida T, Esumi T, Takahara K, Inaba K, Ogawa R, Iida H, Ikehara S. Prevention of senile osteoporosis in SAMP6 mice by intrabone marrow injection of allogeneic bone marrow cells. Stem Cells. 2002;20(6):542–551. doi:https://doi.org/10.1634/stemcells.20-6-542.
- Ocarino NDM, Boeloni JN, Jorgetti V, Gomes DA, Goes AM, Serakides R. Intra-bone marrow injection of mesenchymal stem cells improves the femur bone mass of osteoporotic female rats. Connect Tissue Res. 2010;51(6):426–433. doi:https://doi.org/10.3109/03008201003597049.
- Obermeyer TS, Yonick D, Lauing K, Stock SR, Nauer R, Strotman P, Shankar R, Gamelli R, Stover M, Callaci JJ. Mesenchymal stem cells facilitate fracture repair in an alcohol-induced impaired healing model. J Orthop Trauma. 2012;26(12):712–718. doi:https://doi.org/10.1097/BOT.0b013e3182724298.
- Wang Z, Goh J, Das De S, Ge Z, Ouyang H, Chong JSW, Low SL, Lee EH. Efficacy of bone marrow-derived stem cells in strengthening osteoporotic bone in a rabbit model. Tissue Eng. 2006;12(7):1753–1761. doi:https://doi.org/10.1089/ten.2006.12.1753.
- Benisch P, Schilling T, Klein-Hitpass L, Frey SP, Seefried L, Raaijmakers N, Krug M, Regensburger M, Zeck S, Schinke T, Amling M, Ebert R, Jakob F. The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors. PLoS One. 2012;7(9):e45142. doi:https://doi.org/10.1371/journal.pone.0045142.
- Rodríguez JP, Garat S, Gajardo H, Pino AM, Seitz G. Abnormal osteogenesis in osteoporotic patients is reflected by altered mesenchymal stem cells dynamics. J Cell Biochem. 1999;75(3):414–423. doi:https://doi.org/10.1002/(SICI)1097-4644(19991201)75:3<414::AID-JCB7>3.0.CO;2-C.
- Stenderup K, Justesen J, Eriksen EF, Rattan SI, Kassem M. Number and proliferative capacity of osteogenic stem cells are maintained during aging and in patients with osteoporosis. J Bone Miner Res. 2001;16(6):1120–1129. doi:https://doi.org/10.1359/jbmr.2001.16.6.1120.
- Choi YJ, Song I, Jin Y, Jin H-S, Ji HM, Jeong S-Y, Won -Y-Y, Chung Y-S. Transcriptional profiling of human femoral mesenchymal stem cells in osteoporosis and its association with adipogenesis. Gene. 2017;632(November 2016):7–15. doi:https://doi.org/10.1016/j.gene.2017.08.015.
- Tornero-Esteban P, Peralta-Sastre A, Herranz E, Rodríguez-Rodríguez L, Mucientes A, Abásolo L, Marco F, Fernández-Gutiérrez B, Lamas JR. Altered expression of wnt signaling pathway components in osteogenesis of mesenchymal stem cells in osteoarthritis patients. PLoS One. 2015;10(9):1–17. doi:https://doi.org/10.1371/journal.pone.0137170.
- Jin WJ, Jiang SD, Jiang LS, Dai LY. Differential responsiveness to 17β-estradiol of mesenchymal stem cells from postmenopausal women between osteoporosis and osteoarthritis. Osteoporos Int. 2012;23(10):2469–2478. doi:https://doi.org/10.1007/s00198-011-1859-8.
- Rollín R, Marco F, Camafeita E, Calvo E, López-Durán L, Jover JÁ, López JA, Fernández-Gutiérrez B. Differential proteome of bone marrow mesenchymal stem cells from osteoarthritis patients. Osteoarthr Cartil. 2008;16(8):929–935. doi:https://doi.org/10.1016/j.joca.2007.12.006.
- Čamernik K, Mihelič A, Mihalič R, Haring G, Herman S, Marolt Presen D, Janež A, Trebše R, Marc J, Zupan J. Comprehensive analysis of skeletal muscle- and bone-derived mesenchymal stem/stromal cells in patients with osteoarthritis and femoral neck fracture. Stem Cell Res Ther. 2020;11(1). doi:https://doi.org/10.1186/s13287-020-01657-z.
- Campbell TM, Churchman SM, Gomez A, McGonagle D, Conaghan PG, Ponchel F, Jones E. Mesenchymal stem cell alterations in bone marrow lesions in patients with hip osteoarthritis. Arthritis Rheumatol. 2016;68(7):1648–1659. doi:https://doi.org/10.1002/art.39622.
- Stiehler M, Rauh J, Bünger C, Jacobi A, Vater C, Schildberg T, Liebers C, Günther K-P, Bretschneider H. In vitro characterization of bone marrow stromal cells from osteoarthritic donors. Stem Cell Res. 2016;16(3):782–789. doi:https://doi.org/10.1016/j.scr.2016.03.013.
- Jones E, English A, Churchman SM, Kouroupis D, Boxall SA, Kinsey S, Giannoudis PG, Emery P, McGonagle D. Large-scale extraction and characterization of CD271+ multipotential stromal cells from trabecular bone in health and osteoarthritis: implications for bone regeneration strategies based on uncultured or minimally cultured multipotential stromal cells. Arthritis Rheum. 2010;62(7):1944–1954. doi:https://doi.org/10.1002/art.27451.
- Bork S, Pfister S, Witt H, Horn P, Korn B, Ho AD, Wagner W. DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell. 2010;9(1):54–63. doi:https://doi.org/10.1111/j.1474-9726.2009.00535.x.
- Li Z, Liu C, Xie Z, Song P, Zhao RCH, Guo L, Liu Z, Wu Y. Epigenetic dysregulation in mesenchymal stem cell aging and spontaneous differentiation. PLoS ONE. 2011;6(6):e20526. doi:https://doi.org/10.1371/journal.pone.0020526.
- Ganguly P, El-Jawhari JJ, Giannoudis PV, Burska AN, Ponchel F, Jones EA. Age-related changes in bone marrow mesenchymal stromal cells: a potential impact on osteoporosis and osteoarthritis development. Cell Transplant. 2017;26(9):1520–1529. doi:https://doi.org/10.1177/0963689717721201.
- Antebi B, Pelled G, Gazit D. Stem cell therapy for osteoporosis. Curr Osteoporos Rep. 2014;12(1):41–47. doi:https://doi.org/10.1007/s11914-013-0184-x.
- Scott MA, Levi B, Askarinam A, et al. Brief review of models of ectopic bone formation. Stem Cells Dev. 2012;21(5):655–667. doi:https://doi.org/10.1089/scd.2011.0517.
- Il IG, Kim MK. The relationship between osteoarthritis and osteoporosis. J Bone Miner Metab. 2014;32(2):101–109. doi:https://doi.org/10.1007/s00774-013-0531-0.
- Geusens PP, van den B. Osteoporosis and osteoarthritis: shared mechanisms and epidemiology. Curr Opin Rheumatol. 2016;28(2):97–103. doi:https://doi.org/10.1097/BOR.0000000000000256.
- López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194–1217.
- Infante A, Rodríguez CI. Osteogenesis and aging: lessons from mesenchymal stem cells. Stem Cell Res Ther. 2018;9(1):244. doi:https://doi.org/10.1186/s13287-018-0995-x.
- Roforth MM, Farr JN, Fujita K, McCready LK, Atkinson EJ, Therneau TM, Cunningham JM, Drake MT, Monroe DG, Khosla S. Global transcriptional profiling using RNA sequencing and DNA methylation patterns in highly enriched mesenchymal cells from young versus elderly women. Bone. 2015;76:49–57. doi:https://doi.org/10.1016/j.bone.2015.03.017.
- Beane OS, Fonseca VC, Cooper LL, Koren G, Darling EM. Impact of aging on the regenerative properties of bone marrow-, muscle-, and adipose-derived mesenchymal stem/stromal cells. PLoSOne. 2014;9(12):e115963. doi:https://doi.org/10.1371/journal.pone.0115963.
- Tchkonia T, Zhu Y, Van Deursen J, Campisi J, Kirkland JL. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest. 2013;123(3):966–972. doi:https://doi.org/10.1172/JCI64098.
- Khosla S, Farr JN, Kirkland JL. Inhibiting cellular senescence: a new therapeutic paradigm for age-related osteoporosis. J Clin Endocrinol Metab. 2018;103(4):1282–1290. doi:https://doi.org/10.1210/jc.2017-02694.
- Pignolo RJ, Passos JF, Khosla S, Tchkonia T, Kirkland JL. Reducing senescent cell burden in aging and disease. Trends Mol Med. 2020;26(7):630–638. doi:https://doi.org/10.1016/j.molmed.2020.03.005.
- Khosla S, Farr JN, Tchkonia T, Kirkland JL. The role of cellular senescence in ageing and endocrine disease. Nat Rev Endocrinol. 2020;16(5):263–275. doi:https://doi.org/10.1038/s41574-020-0335-y.